- News & Analysis
Page 553
BenevolentAI generates $115m in funding
The AI-focused drug developer received cash from new and existing investors that could include Lundbeck and Upsher-Smith Laboratories.
Apr 19, 2018Vineti processes series B capital
Founding investor GE Ventures participated in a $33.5m series B round that boosted the gene therapy platform's total funding to more than $47m.
Apr 17, 2018Evelo reveals $100m IPO filing
The gut-based cancer and inflammatory disease drug developer has raised almost $170m from investors including Celgene, GV and Mayo Clinic.
Apr 17, 2018Common Sensing gets series A funding injection
Smart injection technology developer Common Sensing secured $6.6m in a round featuring Haselmeier and Royal Philips.
Apr 16, 2018GlaxoSmithKline picks stake in Orchard
Orchard Therapeutics has licensed a range of gene therapies from GSK, which will get a 19.9% stake in the UCL spinout as part of the deal.
Apr 13, 2018Enterprise boldly goes to $41m series B
The respiratory disease specialist took its overall funding to $55m with a $41.4m round led by Novartis Venture Fund.
Apr 13, 2018GlaxoSmithKline picks stake in Orchard
Orchard Therapeutics has licensed a range of gene therapies from GSK, which will get a 19.9% stake in the company as part of the deal.
Apr 13, 2018About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
© 2025 Mawsonia Ltd. All rights reserved.test regLogin